Is a clinical research professional with experience in both investigational sites and Contract Research Organizations (CROs), serving as a Clinical Research Coordinator (CRC), Clinical Research Associate (CRA), and research operations professional. She has experience coordinating and managing Phase I–III clinical trials across multiple therapeutic areas, including oncology, neurology, cardiometabolic diseases, COPD, infectious diseases, gastroenterology, diabetes, and urology.
Her diverse background in site operations, sponsor/CRO environments, and pharmaceutical research has provided her with a comprehensive understanding of the clinical trial process, enabling her to effectively coordinate study activities, ensure regulatory compliance, support participant recruitment and retention, maintain high-quality clinical data, and collaborate closely with Principal Investigators, sponsors, and multidisciplinary research teams.
Throughout her career, she has held several clinical research positions, including Senior Clinical Research Coordinator, Lead Clinical Research Coordinator, Clinical Research Associate, and Operational & Research Assistant. Prior to her work in clinical research in the United States, she also served as a Medical Scientific Liaison within the pharmaceutical industry, strengthening her expertise in scientific communication and healthcare operations.
She holds a Master in Healthcare Management from ESPAE Graduate School of Management and an Associate in Applied Science in Nursing from Inter American University, graduating Magna Cum Laude. She is also currently pursuing an Associate in Applied Science in Artificial Intelligence at Miami Dade College to further expand her knowledge of emerging technologies in healthcare and clinical research.
At Total Health and Research Center (THRC), she serves as a Clinical Research Coordinator (CRC), where she oversees the coordination and execution of clinical trials, participant visits, regulatory documentation, protocol compliance, and communication with sponsors and CROs. Her commitment to operational excellence, regulatory quality, and patient-centered research contributes to the successful execution of clinical studies across multiple therapeutic areas.
